3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 34954029 | FDI-6 and olaparib synergistically inhibit the growth of pancreatic cancer by repressing BUB1, BRCA1 and CDC25A signaling pathways. | 2022 Jan | 1 |
| 2 | 34092127 | Enhancing the sensitivity of ovarian cancer cells to olaparib via microRNA-20b-mediated cyclin D1 targeting. | 2021 Jun | 2 |
| 3 | 32988624 | An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study. | 2020 Dec | 1 |